A novel multi-biomarker combination predicting relapse from long-term remission after discontinuation of biological drugs in rheumatoid arthritis

Biological disease modifying anti-rheumatic drugs (bDMARDs) show dramatic treatment efficacy in rheumatoid arthritis (RA). Long-term use of bDMARDs, however, has disadvantages such as high costs and infection risk. Therefore, a methodology is needed to predict any future RA relapse. Herein, we repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagatani, Katsuya, Sakashita, Eiji, Endo, Hitoshi, Minota, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531387/
https://www.ncbi.nlm.nih.gov/pubmed/34675298
http://dx.doi.org/10.1038/s41598-021-00357-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531387/
https://www.ncbi.nlm.nih.gov/pubmed/34675298
http://dx.doi.org/10.1038/s41598-021-00357-9

Ejemplares similares